Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC
Status:
Recruiting
Trial end date:
2024-05-31
Target enrollment:
Participant gender:
Summary
This phase II randomized study is to investigate the efficacy and toxicity of fractional
thoracic radiotherapy combined with albumin bound paclitaxel and nedaplatin twice a week in
the treatment of locally advanced non-small cell lung cancer compared with weekly
chemotherapy.